BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26427835)

  • 1. Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients.
    Miller WP; Mantovani LF; Muzic J; Rykken JB; Gawande RS; Lund TC; Shanley RM; Raymond GV; Orchard PJ; Nascene DR
    AJNR Am J Neuroradiol; 2016 Feb; 37(2):367-72. PubMed ID: 26427835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume of Gadolinium Enhancement and Successful Repair of the Blood-Brain Barrier in Cerebral Adrenoleukodystrophy.
    Lund TC; Ng M; Orchard PJ; Loes DJ; Raymond GV; Gupta A; Kenny-Jung D; Nascene DR
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1894-1899. PubMed ID: 32599216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy.
    Kühl JS; Suarez F; Gillett GT; Hemmati PG; Snowden JA; Stadler M; Vuong GL; Aubourg P; Köhler W; Arnold R
    Brain; 2017 Apr; 140(4):953-966. PubMed ID: 28375456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation.
    McKinney AM; Benson JC; Nascene DR; Eisengart J; Salmela MB; Loes DJ; Zhang L; Patel K; Raymond GV; Miller WP
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1713-20. PubMed ID: 27079370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood cerebral X-linked adrenoleukodystrophy: diffusion tensor imaging measurements for prediction of clinical outcome after hematopoietic stem cell transplantation.
    McKinney AM; Nascene D; Miller WP; Eisengart J; Loes D; Benson M; Tolar J; Orchard PJ; Ziegler RS; Zhang L; Provenzale J
    AJNR Am J Neuroradiol; 2013 Mar; 34(3):641-9. PubMed ID: 22899791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.
    Raymond GV; Aubourg P; Paker A; Escolar M; Fischer A; Blanche S; Baruchel A; Dalle JH; Michel G; Prasad V; Miller W; Paadre S; Balser J; Kurtzberg J; Nascene DR; Orchard PJ; Lund T
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):538-548. PubMed ID: 30292747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.
    Miller WP; Rothman SM; Nascene D; Kivisto T; DeFor TE; Ziegler RS; Eisengart J; Leiser K; Raymond G; Lund TC; Tolar J; Orchard PJ
    Blood; 2011 Aug; 118(7):1971-8. PubMed ID: 21586746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
    Eichler F; Duncan C; Musolino PL; Orchard PJ; De Oliveira S; Thrasher AJ; Armant M; Dansereau C; Lund TC; Miller WP; Raymond GV; Sankar R; Shah AJ; Sevin C; Gaspar HB; Gissen P; Amartino H; Bratkovic D; Smith NJC; Paker AM; Shamir E; O'Meara T; Davidson D; Aubourg P; Williams DA
    N Engl J Med; 2017 Oct; 377(17):1630-1638. PubMed ID: 28976817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
    Thibert KA; Raymond GV; Nascene DR; Miller WP; Tolar J; Orchard PJ; Lund TC
    PLoS One; 2012; 7(11):e50430. PubMed ID: 23185624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy.
    Orchard PJ; Markowski TW; Higgins L; Raymond GV; Nascene DR; Miller WP; Pierpont EI; Lund TC
    Sci Rep; 2019 May; 9(1):7858. PubMed ID: 31133696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy.
    Orchard PJ; Nascene DR; Miller WP; Gupta A; Kenney-Jung D; Lund TC
    Blood; 2019 Mar; 133(12):1378-1381. PubMed ID: 30635285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
    Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
    JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy.
    Orchard PJ; Lund T; Miller W; Rothman SM; Raymond G; Nascene D; Basso L; Cloyd J; Tolar J
    J Neuroinflammation; 2011 Oct; 8():144. PubMed ID: 22014002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy.
    Kühl JS; Kupper J; Baqué H; Ebell W; Gärtner J; Korenke C; Spors B; Steffen IG; Strauss G; Voigt S; Weschke B; Weddige A; Köhler W; Steinfeld R
    JAMA Netw Open; 2018 Jul; 1(3):e180769. PubMed ID: 30646031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presymptomatic Lesion in Childhood Cerebral Adrenoleukodystrophy: Timing and Treatment.
    Mallack EJ; Van Haren KP; Torrey A; van de Stadt S; Engelen M; Raymond GV; Fatemi A; Eichler FS
    Neurology; 2022 Aug; 99(5):e512-e520. PubMed ID: 35609989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients.
    Moser HW; Loes DJ; Melhem ER; Raymond GV; Bezman L; Cox CS; Lu SE
    Neuropediatrics; 2000 Oct; 31(5):227-39. PubMed ID: 11204280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations.
    Loes DJ; Stillman AE; Hite S; Shapiro E; Lockman L; Latchaw RE; Moser H; Krivit W
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1767-71. PubMed ID: 7847226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy.
    Baumann M; Korenke GC; Weddige-Diedrichs A; Wilichowski E; Hunneman DH; Wilken B; Brockmann K; Klingebiel T; Niethammer D; Kühl J; Ebell W; Hanefeld F
    Eur J Pediatr; 2003 Jan; 162(1):6-14. PubMed ID: 12486501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy.
    Matsukawa T; Yamamoto T; Honda A; Toya T; Ishiura H; Mitsui J; Tanaka M; Hao A; Shinohara A; Ogura M; Kataoka K; Seo S; Kumano K; Hosoi M; Narukawa K; Yasunaga M; Maki H; Ichikawa M; Nannya Y; Imai Y; Takahashi T; Takahashi Y; Nagasako Y; Yasaka K; Mano KK; Matsukawa MK; Miyagawa T; Hamada M; Sakuishi K; Hayashi T; Iwata A; Terao Y; Shimizu J; Goto J; Mori H; Kunimatsu A; Aoki S; Hayashi S; Nakamura F; Arai S; Momma K; Ogata K; Yoshida T; Abe O; Inazawa J; Toda T; Kurokawa M; Tsuji S
    Brain Commun; 2020; 2(1):fcz048. PubMed ID: 32954314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy.
    Pierpont EI; Nascene DR; Shanley R; Kenney-Jung DL; Ziegler RS; Miller WP; Gupta AO; Lund TC; Orchard PJ; Eisengart JB
    Neurology; 2020 Aug; 95(5):e591-e600. PubMed ID: 32616675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.